Nerve and epidermal growth factors induce the release of the Alzheimer amyloid precursor from PC 12 cell cultures

Biochem Biophys Res Commun. 1989 Oct 31;164(2):664-70. doi: 10.1016/0006-291x(89)91511-8.

Abstract

Antisera against specific sites of the Alzheimer beta Amyloid protein precursor (beta APP) were used to study the effects of nerve and epidermal growth factors on the expression and processing of this protein in PC12 cell cultures. Two major beta APP proteins (140 and 105 kDa) both containing the Kunitz-protease inhibitor insert (KPI), were detected in cell extracts of naive PC12 cells. Treatment of these cultures with nerve growth factor (NGF) induced the release of two beta APP species 125 and 120 kDa, both of which contained the KPI domain and lacked the carboxy-terminal portion of the precursor. The released beta APP contained O-linked sugars. Only one of the released beta APP proteins bound to the lectin Concanavalin A indicating that they differ in their glycosylation. Epidermal growth factor (EGF) also induced the release of beta APP proteins into the culture medium with similar electrophoretic mobilities as those released by NGF.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adrenal Gland Neoplasms / metabolism*
  • Alzheimer Disease / metabolism*
  • Amyloid / biosynthesis*
  • Amyloid / genetics
  • Amyloid beta-Protein Precursor
  • Animals
  • Cell Line
  • Epidermal Growth Factor / pharmacology*
  • Humans
  • Molecular Weight
  • Nerve Growth Factors / pharmacology*
  • Pheochromocytoma / metabolism*
  • Protein Precursors / biosynthesis*
  • Protein Precursors / genetics
  • Protein Processing, Post-Translational
  • Rats

Substances

  • Amyloid
  • Amyloid beta-Protein Precursor
  • Nerve Growth Factors
  • Protein Precursors
  • Epidermal Growth Factor